S100A9 and inflammatory bowel disease: Identification of fecal calprotectin (formed by a heteromeric complex of two subunits, S100A8 and S100A9) is currently used as a routine non-invasive diagnostic tool to distinguish inflammatory bowel disease (IBD) from irritable bowel syndrome, to follow up disease activity and predict disease relapse (97).